Trial intelligence / Profile preview

Fospropofol Disodium for Goal-Directed Sedation in Mechanically Ventilated ICU Patients

ChiCTR2400087605Phase 4Not yet recruiting

Sponsor
Second Hospital of Lanzhou University
Start
Jul 2024
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4 trial of fospropofol disodium in pain, agitation and delirium (3 arms), sponsored by Second Hospital of Lanzhou University. Primary endpoints: Time to achieve sedation goal, Mechanical ventilation duration and 2 more. Planned start Jul 2024; status: not yet recruiting.

02

Drugs

fospropofol disodium
03

Conditions

painagitationdelirium

Beyond the preview

Go deeper on ChiCTR2400087605.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400087605.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call